Cargando…
Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer
SIMPLE SUMMARY: Cervix cancer is largely (95%) caused by human papilloma virus (HPV). Curative treatment for locally advanced cervical cancer (progressed beyond the cervix) is chemotherapy and radiotherapy (CRT), followed by internal radiation (brachytherapy). In approximately 30% of patients the ca...
Autores principales: | Lalondrelle, Susan, Lee, Jen, Cutts, Rosalind J., Garcia Murillas, Isaac, Matthews, Nik, Turner, Nicholas, Harrington, Kevin, Vroobel, Katherine, Moretti, Emily, Bhide, Shreerang A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000151/ https://www.ncbi.nlm.nih.gov/pubmed/36900180 http://dx.doi.org/10.3390/cancers15051387 |
Ejemplares similares
-
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)
por: Lee, Jen Y., et al.
Publicado: (2020) -
Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma
por: Lee, Jen Y, et al.
Publicado: (2017) -
Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study
por: Bryan, Stacey J., et al.
Publicado: (2023) -
HETEROTRANSPLANTATION OF ARGYROPHIL SMALL CELL CARCINOMA OF THE UTERINE CERVIX INTEGRATING HPV16 DNA INTO NUDE MICE
por: Ichimura, Hiroshi, et al.
Publicado: (1988) -
HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa
por: Tuominen, Heidi, et al.
Publicado: (2018)